Eaton Square
Bob Atwill is an accomplished professional with extensive experience in leadership roles across various biotech and healthcare companies. Currently serving as Principal at Eaton Square since February 2016, Bob previously held significant positions, including Head and Senior Vice President for Asia-Pacific Region and Global Business Development at Humanigen, Inc., and CEO of Fitgenes Limited. Additional roles include Director at International Stem Cell Corporation and Senior Vice President at Benitec Biopharma Ltd, among others. Bob holds an Executive MBA from Hult Ashridge, as well as advanced executive development certifications from UCLA and Yale, and a Bachelor of Science in Biochemistry from the University of Bristol.
This person is not in any offices
Eaton Square
Established in 2008M&A and capital professionals in nine offices across US, Australia, China & HK, Singapore, Canada, Israel & India.Core focus on M&A and capital services for services, technology and growth companies In Services: IT Services, Management Consulting and Financial Services, Engineering Services, Health, Oil andGas and Mining servicesIn IT Technology: Big Data, Fintech, Social Media, Data Analytics, Information SecurityIn Life Sciences Technology: Pharmaceuticals, biotechnology, healthcare, nutraceuticalsIn Growth: Health, Medical Devices, Aged Care and areas relevant to our clientsMost clients are:Founders of firms looking to grow or capitalise on the value of their business ($10m - $200m)Global corporations looking to acquire mid-market firms Investors into South East Asia, Australia, North America and IsraelChinese companies looking for outbound acquisitions